CollPlant Biotechnologies Ltd
CLGN- Exchange
- Nasdaq
- Industry
- Orthopedic, Prosthetic & Surgical Appliances & Supplies
- SEC CIK
- 0001631487
No open-market purchases or sales by CollPlant Biotechnologies Ltd insiders were filed in the last 90 days; 16 institutions reported holding it in 13F filings for Q2 2026, worth $582.4K in total; no superinvestor holds it.
13F holders, Q2 2023
Institutional positions in CollPlant Biotechnologies Ltd as of Jun 30, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 17
- 0 vs. Q1 2023
- Shares held
- 1.53M
- +447.8K (+41.3%) vs. Q1 2023
- Total value
- $12.5M
- +$4.86M (+63.8%) vs. Q1 2023
- New holders
- 2
- 2 more added
- Sold out
- 2
- 3 more reduced
1 institution that held it in Q1 2023 haven't filed for Q2 2023 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q1 2023: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting CLGN on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 16 | $582.4K |
| Q1 2026 | 21 | $819.0K |
| Q4 2025 | 17 | $1.93M |
| Q3 2025 | 19 | $4.08M |
| Q2 2025 | 18 | $2.53M |
| Q1 2025 | 16 | $3.33M |
| Q4 2024 | 14 | $4.59M |
| Q3 2024 | 13 | $6.79M |
| Q2 2024 | 16 | $7.39M |
| Q1 2024 | 13 | $7.59M |
| Q4 2023 | 17 | $9.14M |
| Q3 2023 | 18 | $8.55M |
| Q2 2023 | 17 | $12.5M |
| Q1 2023 | 18 | $10.9M |
| Q4 2022 | 18 | $13.1M |
| Q3 2022 | 21 | $10.7M |
| Q2 2022 | 20 | $14.3M |
| Q1 2022 | 16 | $19.5M |
| Q4 2021 | 21 | $29.5M |
| Q3 2021 | 15 | $33.1M |
| Q2 2021 | 16 | $51.9M |
| Q1 2021 | 15 | $24.4M |
Institutions, Q2 2023
Shares, value and share of portfolio for each institution holding CollPlant Biotechnologies Ltd; share changes are against Q1 2023.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Roumell Asset Management, LLC | 577,909 | $4.69M | 9.21% | 00.0% | Unchanged |
| Pinnacle Associates Ltd | 484,653 | $3.95M | 0.07% | +484,653 | New |
| Villere St Denis J & Co LLC | 292,723 | $2.39M | 0.17% | +2,926+1.0% | Added |
| Brown Advisory Inc | 73,849 | $602.6K | 0.00% | 00.0% | Unchanged |
| Benjamin F. Edwards & Company, Inc. | 49,210 | $399.0K | 0.02% | −16,701−25.3% | Reduced |
| Zurcher Kantonalbank (Zurich Cantonalbank) | 23,171 | $187.9K | 0.00% | +51+0.2% | Added |
| Parallel Advisors, LLC | 9,614 | $78.5K | 0.00% | 00.0% | Unchanged |
| Bank of America Corp | 7,389 | $60.3K | 0.00% | 00.0% | Unchanged |
| UBS Group AG | 6,548 | $53.4K | 0.00% | −1,456−18.2% | Reduced |
| The PNC Financial Services Group, Inc. | 3,600 | $29.4K | 0.00% | 00.0% | Unchanged |
| FNY Investment Advisers, LLC | 1,539 | $12.0K | 0.02% | +1,539 | New |
| Geneos Wealth Management Inc. | 750 | $6.08K | 0.00% | 00.0% | Unchanged |
| GWM Advisors LLC | 500 | $4.08K | 0.00% | 00.0% | Unchanged |
| National Bank of Canada | 250 | $1.98K | 0.00% | 00.0% | Unchanged |
| Focused Wealth Management, Inc | 242 | $1.98K | 0.00% | 00.0% | Unchanged |
| Morgan Stanley | 121 | $987 | 0.00% | −50−29.2% | Reduced |
| First Manhattan Co | 100 | $816 | 0.00% | 00.0% | Unchanged |
| Simon Quick Advisors, LLC | 0 | $0 | 0.00% | −13,202−100.0% | Sold out |
| Shay Capital LLC | 0 | $0 | 0.00% | −10,000−100.0% | Sold out |
| Investment Management of Virginia LLC | – | – | – | – | Not filed |